ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304268 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Ruth Tamara Valencia-Portillo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratório de Soroepidemiologia, Universidade de Sao Paulo, Sao Paulo, São Paulo…. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Enzyme-Linked Immunosorbent Assay, Antigens, Protozoan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
American tegumentary leishmaniasis (ATL) diagnosis is an open question, and the search for a solution is urgent. The available tests that detect the etiological agent of the infection are specific for ATL diagnosis. However, they present disadvantages, such as low sensitivity and the need for invasive procedures to obtain the samples. Immunological methods (leishmanin skin test and search for anti- Leishmania antibodies) are good alternatives to the etiological diagnosis of ATL. Presently, we face problems with disease confirmation due to the discontinuity in the production of leishmanin skin test antigen, particularly in resource-poor settings. Aiming to diagnose ATL, we validated rLb6H-ELISA for IgG antibodies using 1,091 samples from leishmaniasis patients and healthy controls, divided into four panels, living in 19 Brazilian endemic and non-endemic states. The rLb6H-ELISA showed a sensitivity of 98.6% and a specificity of 100.0%, with the reference panel comprising 70 ATL patient samples and 70 healthy controls. The reproducibility evaluation showed a coefficient of variation of positive samples ≤ 8.20% for repeatability, ≤ 17,97% for reproducibility, and ≤ 8.12% for homogeneity. The plates sensitized with rLb6H were stable at 4°C and -20°C for 180 days and 37°C for seven days, indicating 12 months of validity. In samples of ATL patients from five research and healthcare centers in endemic and non-endemic areas, rLb6H-ELISA showed a sensitivity of 84.0%; no significant statistical difference was observed among the five centers (chi-square test, p = 0.13). In samples of healthy controls from four areas with different endemicity, a specificity of 92.4% was obtained; lower specificity was obtained in a visceral leishmaniasis high endemicity locality (chi-square test, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratório de Soroepidemiologia, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil.
- Instituto de Infectologia Emílio Ribas, Secretaria de Saúde do Estado de Sao Paulo, Sao Paulo, São Paulo, Brazil.
- Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Laboratório de Protozoologia, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil.
- Faculdade de Medicina, Departamento de Medicina Preventiva, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil.
- Global Medical Affairs, MSD in Brazil, Sao Paulo, São Paulo, Brazil.
- Centro de Pesquisas Aggeu Magalhães, Fundacao Oswaldo Cruz, Recife, Pernambuco, Brazil.
ORCID-Profile: Amanda Azevedo Bittencourt, Hiro Goto, Maria Carmen Arroyo Sanchez
Förderung
- São Paulo Research Foundation
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Laboratórios de Investigação Médica - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Zitieren
APA
Valencia-Portillo, R. T., Lindoso, J. A., Celeste, B. J., Bittencourt, A. A., de Brito, M. E. F., Duthie, M. S., Guderian, J., Guerra, J., Oliveira, A. L. L., Reed, S., Rocha, M. C., Santos, N. T., Silveira, F. T., Goto, H., & Sanchez, M. C. A. (2024). ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis. PLOS ONE. https://doi.org/10.1371/journal.pone.0304268
Vancouver
Valencia-Portillo RT, Lindoso JA, Celeste BJ, Bittencourt AA, de Brito MEF, Duthie MS, et al. ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis. PLOS ONE. 2024. doi:10.1371/journal.pone.0304268
BibTeX
@article{ValenciaPortillo2024,
author = {Valencia-Portillo, Ruth Tamara and Lindoso, José Angelo and Celeste, Beatriz Julieta and Bittencourt, Amanda Azevedo and de Brito, Maria Edileuza Felinto and Duthie, Malcolm Scott and Guderian, Jeffery and Guerra, Jorge and Oliveira, Ana Lúcia Lyrio and Reed, Steven and Rocha, Mussya Cisotto and Santos, Nicolle Tayná and Silveira, Fernando Tobias and Goto, Hiro and Sanchez, Maria Carmen Arroyo},
title = {ELISA with recombinant antigen Lb6H validated for the diagnosis of American tegumentary leishmaniasis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304268}
}
EUVIMED